[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate

C112H124F5N27O22S6 — CID 157386019

IUPAC[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate
SMILESCOC1CN(S(=O)(=O)Nc2ccc(-c3nnn(C)c3CC(=O)O[C@H](C)c3cccc(F)c3)nc2C)C1.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C(C)C.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C1CC1.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C1COC1.Cc1ncc(S(=O)(=O)Nc2ccc(-c3nnn(C)c3CC(=O)O[C@H](C)c3cccc(F)c3)nc2C)s1
InChIInChI=1S/C23H27FN6O5S.C23H23FN6O4S2.C22H24FN5O5S.C22H24FN5O4S.C22H26FN5O4S/c1-14-19(27-36(32,33)30-12-18(13-30)34-4)8-9-20(25-14)23-21(29(3)28-26-23)11-22(31)35-15(2)16-6-5-7-17(24)10-16;1-13-18(28-36(32,33)22-12-25-15(3)35-22)8-9-19(26-13)23-20(30(4)29-27-23)11-21(31)34-14(2)16-6-5-7-17(24)10-16;1-13-18(26-34(30,31)17-11-32-12-17)7-8-19(24-13)22-20(28(3)27-25-22)10-21(29)33-14(2)15-5-4-6-16(23)9-15;1-13-18(26-33(30,31)17-7-8-17)9-10-19(24-13)22-20(28(3)27-25-22)12-21(29)32-14(2)15-5-4-6-16(23)11-15;1-13(2)33(30,31)26-18-9-10-19(24-14(18)3)22-20(28(5)27-25-22)12-21(29)32-15(4)16-7-6-8-17(23)11-16/h5-10,15,18,27H,11-13H2,1-4H3;5-10,12,14,28H,11H2,1-4H3;4-9,14,17,26H,10-12H2,1-3H3;4-6,9-11,14,17,26H,7-8,12H2,1-3H3;6-11,13,15,26H,12H2,1-5H3/t15-;3*14-;15-/m11111/s1
InChIKeyBLKYVJXPVODKGD-BQIKVJBFSA-N
MW2487.78 g/mol
LogP14.61
Rot. Bonds41

About [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate

[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate (PubChem CID 157386019) has the molecular formula C112H124F5N27O22S6 and a molecular weight of 2487.78 g/mol. Its IUPAC name is [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate.

Molecular Properties

Compound Name[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate
PubChem CID157386019
Molecular FormulaC112H124F5N27O22S6
Molecular Weight2487.78 g/mol
Exact Mass2485.77
IUPAC Name[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate
SMILESCOC1CN(S(=O)(=O)Nc2ccc(-c3nnn(C)c3CC(=O)O[C@H](C)c3cccc(F)c3)nc2C)C1.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C(C)C.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C1CC1.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C1COC1.Cc1ncc(S(=O)(=O)Nc2ccc(-c3nnn(C)c3CC(=O)O[C@H](C)c3cccc(F)c3)nc2C)s1
InChIInChI=1S/C23H27FN6O5S.C23H23FN6O4S2.C22H24FN5O5S.C22H24FN5O4S.C22H26FN5O4S/c1-14-19(27-36(32,33)30-12-18(13-30)34-4)8-9-20(25-14)23-21(29(3)28-26-23)11-22(31)35-15(2)16-6-5-7-17(24)10-16;1-13-18(28-36(32,33)22-12-25-15(3)35-22)8-9-19(26-13)23-20(30(4)29-27-23)11-21(31)34-14(2)16-6-5-7-17(24)10-16;1-13-18(26-34(30,31)17-11-32-12-17)7-8-19(24-13)22-20(28(3)27-25-22)10-21(29)33-14(2)15-5-4-6-16(23)9-15;1-13-18(26-33(30,31)17-7-8-17)9-10-19(24-13)22-20(28(3)27-25-22)12-21(29)32-14(2)15-5-4-6-16(23)11-15;1-13(2)33(30,31)26-18-9-10-19(24-14(18)3)22-20(28(5)27-25-22)12-21(29)32-15(4)16-7-6-8-17(23)11-16/h5-10,15,18,27H,11-13H2,1-4H3;5-10,12,14,28H,11H2,1-4H3;4-9,14,17,26H,10-12H2,1-3H3;4-6,9-11,14,17,26H,7-8,12H2,1-3H3;6-11,13,15,26H,12H2,1-5H3/t15-;3*14-;15-/m11111/s1
InChIKeyBLKYVJXPVODKGD-BQIKVJBFSA-N
XLogP14.61
TPSA614.94 Ų
H-Bond Donors5
H-Bond Acceptors44
Rotatable Bonds41
Heavy Atoms172
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002487.78
LogP ≤ 514.61
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1044

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate?
The IUPAC name of [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate (CID 157386019) is [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate.
What is the SMILES notation for [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate?
The canonical SMILES for [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate is COC1CN(S(=O)(=O)Nc2ccc(-c3nnn(C)c3CC(=O)O[C@H](C)c3cccc(F)c3)nc2C)C1.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C(C)C.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C1CC1.Cc1nc(-c2nnn(C)c2CC(=O)O[C@H](C)c2cccc(F)c2)ccc1NS(=O)(=O)C1COC1.Cc1ncc(S(=O)(=O)Nc2ccc(-c3nnn(C)c3CC(=O)O[C@H](C)c3cccc(F)c3)nc2C)s1.
What is the InChIKey of [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate?
The InChIKey is BLKYVJXPVODKGD-BQIKVJBFSA-N. The full InChI is InChI=1S/C23H27FN6O5S.C23H23FN6O4S2.C22H24FN5O5S.C22H24FN5O4S.C22H26FN5O4S/c1-14-19(27-36(32,33)30-12-18(13-30)34-4)8-9-20(25-14)23-21(29(3)28-26-23)11-22(31)35-15(2)16-6-5-7-17(24)10-16;1-13-18(28-36(32,33)22-12-25-15(3)35-22)8-9-19(26-13)23-20(30(4)29-27-23)11-21(31)34-14(2)16-6-5-7-17(24)10-16;1-13-18(26-34(30,31)17-11-32-12-17)7-8-19(24-13)22-20(28(3)27-25-22)10-21(29)33-14(2)15-5-4-6-16(23)9-15;1-13-18(26-33(30,31)17-7-8-17)9-10-19(24-13)22-20(28(3)27-25-22)12-21(29)32-14(2)15-5-4-6-16(23)11-15;1-13(2)33(30,31)26-18-9-10-19(24-14(18)3)22-20(28(5)27-25-22)12-21(29)32-15(4)16-7-6-8-17(23)11-16/h5-10,15,18,27H,11-13H2,1-4H3;5-10,12,14,28H,11H2,1-4H3;4-9,14,17,26H,10-12H2,1-3H3;4-6,9-11,14,17,26H,7-8,12H2,1-3H3;6-11,13,15,26H,12H2,1-5H3/t15-;3*14-;15-/m11111/s1.
What are the key properties of [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate?
[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate has a molecular weight of 2487.78 g/mol, XLogP of 14.61, 41 rotatable bonds, 5 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-(cyclopropylsulfonylamino)-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[5-[5-[(3-methoxyazetidin-1-yl)sulfonylamino]-6-methyl-2-pyridinyl]-3-methyltriazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-[(2-methyl-1,3-thiazol-5-yl)sulfonylamino]-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(oxetan-3-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate;[(1R)-1-(3-fluorophenyl)ethyl] 2-[3-methyl-5-[6-methyl-5-(propan-2-ylsulfonylamino)-2-pyridinyl]triazol-4-yl]acetate is sourced from PubChem (CID 157386019), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).